8-K Announcements
6Material company update
May 12, 2026·SEC
Material company update
Apr 29, 2026·SEC
Material company update
Mar 31, 2026·SEC
Solesence, Inc. Common Stock(SLSN)Earnings, Financials & Key Ratios
SLSN•NASDAQ
67.0× P/E·Price updated Jun 19, 2026
AboutSolésence, Inc., formerly Nanophase Technologies Corporation, is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products. The company partners with global and indie brands, leveraging its proprietary Active Stress Defense™ technology suite to bring environmental protection beauty products to market.Show more
- Revenue$62M+18.6%
- EBITDA$2M-59.3%
- Net Income$2M-57.7%
- EPS (Diluted)0.02-71.4%
- Gross Margin25.82%-16.5%
- EBITDA Margin3.98%-65.6%
- Operating Margin2.53%-74.2%
- Net Margin2.88%-64.4%
- ROE10.99%-78.1%
SLSN Key Insights
Solesence, Inc. Common Stock (SLSN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Efficient asset utilization: 1.2x turnover
✗Weaknesses
- ✗Weak Piotroski F-Score: 3/9
- ✗Negative free cash flow
- ✗Shares diluted 11.6% in last year
- ✗Thin 5Y average net margin of 0.0%
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when SLSN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
SLSN Price & Volume
Solesence, Inc. Common Stock (SLSN) stock price & volume — 10-year historical chart
Loading chart...
SLSN Growth Metrics
Solesence, Inc. Common Stock (SLSN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years18.48%
TTM5.76%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-72.42%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-68.13%
Return on Capital
10 Years2.37%
5 Years2.37%
3 Years3.59%
Last Year5.21%
SLSN Recent Earnings
Solesence, Inc. Common Stock (SLSN) EPS & revenue vs analyst estimates — last 4 quarters
Q2 2026Latest
May 12, 2026Metric
Actual
Est
EPS
$0.01
—
Rev
$13M
—
Q2 2026
Mar 31, 2026Metric
Actual
Est
EPS
$0.00
—
Rev
$12M
—
Q4 2025
Nov 11, 2025Metric
Actual
Est
EPS
$0.02
—
Rev
$15M
—
Q3 2025
Jul 31, 2025Metric
Actual
Est
EPS
$0.04
—
Rev
$20M
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 12, 2026 | $0.01 | $13M |
| Q2 2026 | Mar 31, 2026 | $0.00 | $12M |
| Q4 2025 | Nov 11, 2025 | $0.02 | $15M |
| Q3 2025 | Jul 31, 2025 | $0.04 | $20M |
Based on last 10 quarters of dataView full earnings history →
SLSN Peer Comparison
Solesence, Inc. Common Stock (SLSN) competitors in Personal Care and Beauty Products — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 SKIN | 85.9M | 0.66 | -4.14 | -10.02% | -2.03% | -9.41% | 6.20 | |
 RVLV | 1.55B | 21.79 | 25.34 | 8.48% | 5.05% | 12.84% | 0.06 | |
 ELF | 3.82B | 64.20 | 145.91 | 24.59% | 3.34% | 5.16% | 0.81 | |
 COTY | 1.72B | 1.95 | -4.43 | -3.68% | -9.26% | -14.13% | 1.07 | |
 IPAR | 3.17B | 99.09 | 18.91 | 2.49% | 13.46% | 18.37% | 0.20 | |
 EL | 30.62B | 84.81 | -26.92 | -8.46% | -1.67% | -6.29% | 2.44 | |
 ULTA | 19.61B | 456.13 | 17.79 | 9.71% | 9.36% | 44.77% | 0.78 | |
 HIMS | 7.79B | 35.47 | 69.55 | 59% | -0.56% | -2.48% | 2.34 |
Compare SLSN vs Peers
Solesence, Inc. Common Stock (SLSN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
SLSN Income Statement
Solesence, Inc. Common Stock (SLSN) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|
Sales/Revenue | 29.48M | 37.32M | 37.3M | 52.35M | 62.06M | 60.4M |
Revenue Growth % | - | 26.61% | -0.05% | 40.35% | 18.56% | 5.76% |
Cost of Goods Sold | 20.79M | 28.96M | 29.47M | 36.16M | 46.04M | 44.4M |
COGS % of Revenue | 70.52% | 77.6% | 79.02% | 69.08% | 74.18% | - |
Gross Profit | 8.69M▲ 0% | 8.36M▼ 3.8% | 7.83M▼ 6.4% | 16.19M▲ 106.9% | 16.03M▼ 1.0% | 16M▲ 0% |
Gross Margin % | 29.48% | 22.4% | 20.98% | 30.92% | 25.82% | 26.49% |
Gross Profit Growth % | - | -3.8% | -6.4% | 106.88% | -0.99% | - |
Operating Expenses | 6.13M | 10.62M | 11.37M | 11.06M | 14.46M | 15.19M |
OpEx % of Revenue | 20.8% | 28.45% | 30.49% | 21.12% | 23.29% | - |
Selling, General & Admin | 3.9M | 7.58M | 7.53M | 7.22M | 10.38M | 11.08M |
SG&A % of Revenue | 13.22% | 20.32% | 20.2% | 13.79% | 16.72% | - |
Research & Development | 2.23M | 3.04M | 3.84M | 3.84M | 4.08M | 4.11M |
R&D % of Revenue | 7.58% | 8.14% | 10.29% | 7.33% | 6.57% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | 2.56M▲ 0% | -2.26M▼ 188.2% | -3.55M▼ 57.0% | 5.13M▲ 244.7% | 1.57M▼ 69.4% | 811K▲ 0% |
Operating Margin % | 8.68% | -6.05% | -9.51% | 9.8% | 2.53% | 1.34% |
Operating Income Growth % | - | -188.24% | -57.04% | 244.73% | -69.37% | - |
EBITDA | 3.01M | -1.69M | -2.8M | 6.06M | 2.47M | 1.79M |
EBITDA Margin % | 10.22% | -4.53% | -7.52% | 11.58% | 3.98% | 2.97% |
EBITDA Growth % | - | -156.12% | -65.82% | 316.12% | -59.26% | -65.51% |
D&A (Non-Cash Add-back) | 454K | 567K | 742K | 928K | 897K | 982K |
EBIT | 3.51M | -2.26M | -3.55M | 5.13M | 1.57M | 811K |
Net Interest Income | -1.15M | -382K | -838K | -670K | -931K | -1.02M |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 1.15M | 382K | 838K | 670K | 931K | 1.02M |
Other Income/Expense | -202K | -382K | -838K | -670K | 291K | 206K |
Pretax Income | 2.36M▲ 0% | -2.64M▼ 212.0% | -4.38M▼ 66.1% | 4.46M▲ 201.8% | 1.86M▼ 58.2% | 1.02M▲ 0% |
Pretax Margin % | 8% | -7.07% | -11.75% | 8.52% | 3% | 1.68% |
Income Tax | 37K | -17K | 6K | 227K | 73K | 73K |
Effective Tax Rate % | 1.57% | 0.64% | -0.14% | 5.09% | 3.92% | 7.18% |
Net Income | 2.32M▲ 0% | -2.62M▼ 213.1% | -4.39M▼ 67.4% | 4.24M▲ 196.5% | 1.79M▼ 57.7% | 944K▲ 0% |
Net Margin % | 7.87% | -7.03% | -11.77% | 8.09% | 2.88% | 1.56% |
Net Income Growth % | - | -213.06% | -67.37% | 196.47% | -57.73% | -72.42% |
Net Income (Continuing) | 2.32M | -2.62M | -4.39M | 4.24M | 1.79M | 944K |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 0.05▲ 0% | -0.05▼ 206.8% | -0.09▼ 65.9% | 0.07▲ 179.0% | 0.02▼ 71.4% | 0.01▲ 0% |
EPS Growth % | - | -206.8% | -65.92% | 179.01% | -71.43% | -68.13% |
EPS (Basic) | 0.05 | -0.05 | -0.09 | 0.07 | 0.03 | - |
Diluted Shares Outstanding | 47.04M | 49.12M | 49.56M | 65.03M | 72.58M | 70.63M |
Basic Shares Outstanding | 45.02M | 49.12M | 49.56M | 62.35M | 70.34M | 70.63M |
Dividend Payout Ratio | - | - | - | - | - | - |
SLSN Balance Sheet
Solesence, Inc. Common Stock (SLSN) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|
Total Current Assets | 11.6M | 16.63M | 16.3M | 29.35M | 28.78M | 26.41M |
Cash & Short-Term Investments | 657K | 2.19M | 1.72M | 1.41M | 1.29M | 573K |
Cash Only | 657K | 2.19M | 1.72M | 1.41M | 1.29M | 573K |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 3.94M | 4.73M | 3.47M | 4.87M | 6.84M | 6.38M |
Days Sales Outstanding | 48.75 | 46.3 | 33.93 | 33.95 | 40.2 | 51.33 |
Inventory | 6.09M | 8.84M | 10.03M | 20.27M | 18.51M | 17.56M |
Days Inventory Outstanding | 107.03 | 111.41 | 124.23 | 204.58 | 146.76 | 153.68 |
Other Current Assets | 0 | 866K | 1.08M | 2.8M | 2.14M | 1.9M |
Total Non-Current Assets | 16.8M | 16.93M | 16.58M | 20.65M | 21.28M | 21.38M |
Property, Plant & Equipment | 16.79M | 16.93M | 16.57M | 20.65M | 6.91M | 21.34M |
Fixed Asset Turnover | 1.76x | 2.20x | 2.25x | 2.53x | 8.98x | 3.42x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 8K | 6K | 4K | 3K | 14.37M | 37K |
Total Assets | 28.39M▲ 0% | 33.56M▲ 18.2% | 32.88M▼ 2.0% | 50M▲ 52.1% | 50.05M▲ 0.1% | 47.79M▲ 0% |
Asset Turnover | 1.04x | 1.11x | 1.13x | 1.05x | 1.24x | 1.14x |
Asset Growth % | - | 18.19% | -2.02% | 52.07% | 0.11% | 43.07% |
Total Current Liabilities | 7.34M | 13.84M | 15.59M | 25.77M | 13.93M | 12.69M |
Accounts Payable | 3.89M | 6.77M | 6.39M | 10.69M | 4.39M | 4.67M |
Days Payables Outstanding | 68.24 | 85.28 | 79.11 | 107.91 | 34.81 | 42.71 |
Short-Term Debt | 1.35M | 4.28M | 4.81M | 5M | 4.77M | 4.34M |
Deferred Revenue (Current) | 905K | 2.23M | 2.35M | 5.57M | 930K | 4.26M |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 2.51M |
Current Ratio | 1.58x | 1.20x | 1.05x | 1.14x | 2.07x | 2.08x |
Quick Ratio | 0.75x | 0.56x | 0.40x | 0.35x | 0.74x | 0.70x |
Cash Conversion Cycle | 87.55 | 72.43 | 79.05 | 130.62 | 152.16 | 162.3 |
Total Non-Current Liabilities | 13.59M | 14.07M | 15.39M | 9.28M | 18.49M | 18.14M |
Long-Term Debt | 1M | 4M | 6M | 0 | 10.5M | 10.5M |
Capital Lease Obligations | 11.71M | 9.82M | 9.15M | 9.04M | 7.8M | 31.86M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 222K | 230K | 238K | 246K | 194K | 196K |
Total Liabilities | 20.93M | 27.91M | 30.98M | 35.06M | 32.42M | 30.83M |
Total Debt | 14.75M | 18.11M | 21.26M | 15.3M | 24.32M | 22.28M |
Net Debt | 14.09M | 15.92M | 19.54M | 13.89M | 23.03M | 21.71M |
Debt / Equity | 1.98x | 3.20x | 11.18x | 1.02x | 1.38x | 1.31x |
Debt / EBITDA | 4.90x | - | - | 2.52x | 9.85x | 12.43x |
Net Debt / EBITDA | 4.68x | - | - | 2.29x | 9.33x | 12.11x |
Interest Coverage | 3.04x | -5.91x | -4.23x | 7.66x | 1.69x | 0.80x |
Total Equity | 7.46M▲ 0% | 5.65M▼ 24.3% | 1.9M▼ 66.3% | 14.95M▲ 685.8% | 17.63M▲ 18.0% | 16.97M▲ 0% |
Equity Growth % | - | -24.33% | -66.33% | 685.8% | 17.98% | 96.03% |
Book Value per Share | 0.16 | 0.12 | 0.04 | 0.23 | 0.24 | 0.24 |
Total Shareholders' Equity | 7.46M | 5.65M | 1.9M | 14.95M | 17.63M | 16.97M |
Common Stock | 489K | 493K | 496K | 700K | 706K | 706K |
Retained Earnings | -97.45M | -100.07M | -104.66M | -100.43M | -98.64M | -99.4M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
SLSN Cash Flow Statement
Solesence, Inc. Common Stock (SLSN) cash flow — operating, investing & free cash flow history
| Metric | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|
Cash from Operations | 2.32M | -1.65M | -2.01M | 1.97M | -8.57M | 171K |
Operating CF Margin % | 7.87% | -4.42% | -5.38% | 3.77% | -13.8% | - |
Operating CF Growth % | - | -171.09% | -21.58% | 198.26% | -534.65% | -71.4% |
Net Income | 2.32M | -2.62M | -4.39M | 4.24M | 1.79M | 944K |
Depreciation & Amortization | 454K | 567K | 742K | 928K | 897K | 984K |
Stock-Based Compensation | 160K | 625K | 773K | 725K | 575K | 448K |
Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | -49K | 2.57M | 0 | 0 | 0 | 83K |
Working Capital Changes | -564K | -2.79M | 869K | -3.92M | -11.83M | -2.29M |
Change in Receivables | -1M | -797K | 1.06M | -1.4M | -1.97M | 2.71M |
Change in Inventory | -1.75M | -2.74M | -1.19M | -10.24M | 1.76M | 4.35M |
Change in Payables | 1.03M | 0 | -503K | 2.4M | -5.38M | -4.35M |
Cash from Investing | -1.87M | -2.82M | -1.05M | -4.56M | -2.14M | -2.8M |
Capital Expenditures | -1.87M | -2.82M | -1.05M | -4.56M | -2.14M | -3.76M |
CapEx % of Revenue | 6.36% | 7.56% | 2.82% | 8.71% | 3.45% | 6.23% |
Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - |
Other Investing | 0 | 0 | 0 | 0 | 0 | 958K |
Cash from Financing | -747K | 6M | 2.59M | 2.27M | 10.59M | 1.39M |
Debt Issued (Net) | -981K | -111K | 2.52M | -5.81M | 10.27M | 1.05M |
Equity Issued (Net) | 0 | 0 | 0 | 6M | 323K | 16K |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | 234K | 6.11M | 73K | 2.08M | 0 | 319K |
Net Change in Cash | -300K▲ 0% | 1.53M▲ 609.7% | -464K▼ 130.3% | -313K▲ 32.5% | -121K▲ 61.3% | -1.24M▲ 0% |
Free Cash Flow | 447K▲ 0% | -4.47M▼ 1100.7% | -3.06M▲ 31.7% | -2.59M▲ 15.4% | -10.71M▼ 314.0% | -2.18M▲ 0% |
FCF Margin % | 1.52% | -11.99% | -8.2% | -4.94% | -17.26% | -3.61% |
FCF Growth % | - | -1100.67% | 31.66% | 15.37% | -313.99% | 62.8% |
FCF per Share | 0.01 | -0.09 | -0.06 | -0.04 | -0.15 | -0.03 |
FCF Conversion (FCF/Net Income) | 1.00x | 0.63x | 0.46x | 0.47x | -4.79x | -2.31x |
Interest Paid | 218K | 333K | 752K | 637K | 0 | 594K |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 |
SLSN Key Ratios
Solesence, Inc. Common Stock (SLSN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
Return on Equity (ROE) | -40% | -116.28% | 50.27% | 10.99% | 5.39% |
Return on Invested Capital (ROIC) | -7.85% | -12.37% | 15.31% | 3.39% | 1.5% |
Gross Margin | 22.4% | 20.98% | 30.92% | 25.82% | 26.49% |
Net Margin | -7.03% | -11.77% | 8.09% | 2.88% | 1.56% |
Debt / Equity | 3.20x | 11.18x | 1.02x | 1.38x | 1.31x |
Interest Coverage | -5.91x | -4.23x | 7.66x | 1.69x | 0.80x |
FCF Conversion | 0.63x | 0.46x | 0.47x | -4.79x | -2.31x |
Revenue Growth | 26.61% | -0.05% | 40.35% | 18.56% | 5.76% |
Related:SLSN Dividend History·SLSN Revenue History·SLSN Price History·SLSN P/E History·SLSN Financial Ratios·SLSN Institutional Holders
SLSN SEC Filings & Documents
Solesence, Inc. Common Stock (SLSN) SEC filings — annual & quarterly reports (10-K, 10-Q)
SLSN Frequently Asked Questions
Solesence, Inc. Common Stock (SLSN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Solesence, Inc. Common Stock (SLSN) reported $60.4M in revenue for fiscal year 2025. This represents a 105% increase from $29.5M in 2021.
Solesence, Inc. Common Stock (SLSN) grew revenue by 18.6% over the past year. This is strong growth.
Yes, Solesence, Inc. Common Stock (SLSN) is profitable, generating $0.9M in net income for fiscal year 2025 (2.9% net margin).
Dividend & Returns
Solesence, Inc. Common Stock (SLSN) has a return on equity (ROE) of 11.0%. This is reasonable for most industries.
Solesence, Inc. Common Stock (SLSN) had negative free cash flow of $2.2M in fiscal year 2025, likely due to heavy capital investments.